People

Elizabeth Kertowidjojo, MD PhD

Update on Uterine Mesenchymal Neoplasms.
Kertowidjojo EC, Bennett JA. Update on Uterine Mesenchymal Neoplasms. Surg Pathol Clin. 2022 Jun; 15(2):315-340.
PMID: 35715164

CTNNB1-mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma.
Mendoza R, Kertowidjojo E. CTNNB1-mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma. Int J Gynecol Pathol. 2022 May 20.
PMID: 35639408

ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment.
Dessources K, Miller KM, Kertowidjojo E, Da Cruz Paula A, Zou Y, Selenica P, da Silva EM, Benayed R, Ashley CW, Abu-Rustum NR, Dogan S, Soslow RA, Hensley ML, Weigelt B, Chiang S. ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment. Mod Pathol. 2022 07; 35(7):972-978.
PMID: 34961764

GTF2A1-NCOA2-Associated Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Shows Focal Rhabdoid Morphology and Aggressive Behavior.
Devereaux KA, Kertowidjojo E, Natale K, Ewalt MD, Soslow RA, Hodgson A. GTF2A1-NCOA2-Associated Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Shows Focal Rhabdoid Morphology and Aggressive Behavior. Am J Surg Pathol. 2021 12 01; 45(12):1725-1728.
PMID: 34334688

Histological Changes Observed in Placentas Exposed to Medication-Assisted Treatment.
Staszewski C, Herrera KM, Kertowidjojo E, Ly V, Iovino N, Garretto D, Kaplan C, Persad MD, Garry DJ. Histological Changes Observed in Placentas Exposed to Medication-Assisted Treatment. J Pregnancy. 2021; 2021:2175026.
PMID: 34659831

New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions.
Causa Andrieu P, Woo S, Kim TH, Kertowidjojo E, Hodgson A, Sun S. New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions. Curr Opin Oncol. 2021 09 01; 33(5):464-475.
PMID: 34172593

Insufficient evidence of endocervical origin in germline BRCA1 and MSH2-associated tumors.
Kertowidjojo E, Park KJ, Hodgson A. Insufficient evidence of endocervical origin in germline BRCA1 and MSH2-associated tumors. Tumori. 2021 12; 107(6):578-579.
PMID: 33525990

Primitive neuroectodermal tumor of the uterus: Excellent clinical response following a multimodal treatment approach.
Khorasanchi A, Kertowidjojo E, Kim S, Burke W, Kudelka A. Primitive neuroectodermal tumor of the uterus: Excellent clinical response following a multimodal treatment approach. Gynecol Oncol Rep. 2020 May; 32:100550.
PMID: 32149182

Copy number aberrations in B-cell lymphoma: A call for consideration in prognosis determination and therapy.
Kertowidjojo E, Sticco K, Ahmed T, Ma Y, Berger-Zaslav AL. Copy number aberrations in B-cell lymphoma: A call for consideration in prognosis determination and therapy. Leuk Res Rep. 2019; 11:38-40.
PMID: 31080727

Divergent outcomes of fructose consumption on exercise capacity of rats: friend or foe.
Sun A, Huang A, Kertowidjojo E, Song S, Hintze TH, Sun D. Divergent outcomes of fructose consumption on exercise capacity of rats: friend or foe. J Appl Physiol (1985). 2017 Feb 01; 122(2):368-375.
PMID: 27909228

View All Publications